Cystinosis clinical trials at UCSD

1 research study open to eligible people

Showing trials for

  • Stem Cell Gene Therapy for Cystinosis

    open to eligible people ages 18 years and up

    This study is a Phase 1/2 clinical trial that will assess the safety and efficacy of enriched gene-corrected hematopoietic stem cells isolated from patients affected with cystinosis. (Investigational Product: CTNS-RD-04 or CTNS-RD-04-LB, where the suffix "-LB" stands for LentiBOOST)

    La Jolla, California

Our lead scientists for Cystinosis research studies include .

Last updated: